DexCom, Inc. Share Price Deutsche Boerse AG
Stocks
DC4
US2521311074
Medical Equipment, Supplies & Distribution
|
Market Closed -
Deutsche Boerse AG
01:25:01 10/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 71.80 EUR | -1.10% |
|
-7.47% | +25.92% |
| 07:05pm | DexCom, Inc. Presents at Wells Fargo 21st Annual Healthcare Conference, Sep-09-2026 08:00 AM | |
| 25/08 | Dexcom Insider Sold Shares Worth $2,408,242, According to a Recent SEC Filing | MT |
| Market Cap | 3.19TCr 2.74TCr 2.58TCr 2.35TCr 4.41TCr 3,03500Cr 4.42TCr 31TCr 12TCr 1,54600Cr 12TCr 12TCr 4,89900Cr | P/E 2026 * |
33.6x | P/E 2027 * | 28.3x |
|---|---|---|---|---|---|
| Enterprise Value | 3.11TCr 2.68TCr 2.52TCr 2.3TCr 4.3TCr 2,96300Cr 4.32TCr 30TCr 12TCr 1,50900Cr 12TCr 11TCr 4,78200Cr | EV / Sales 2026 * |
5.95x | EV / Sales 2027 * | 5.32x |
| Free-Float |
91.27% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| DXCM | Delayed | |
CBOE
| DXCM | Real-time | |
|
Mexican S.E.
| DXCM * | End-of-day quote | |
|
Tradegate
| DC4 | Real-time | |
|
Boerse Muenchen
| DC4 | Real-time | |
|
London S.E.
| 0A4M | Delayed | |
|
Borsa Italiana
| 1DXCM | End-of-day quote | |
|
Deutsche Boerse AG
| DC4 | Delayed | |
|
Börse Stuttgart
| DC4 | Delayed | |
|
Xetra
| DC4 | Delayed | |
|
Wiener Boerse
| DXCM | End-of-day quote | |
|
Swiss Exchange
| DXCM | Delayed | |
|
Swiss Exchange
| DXCM | Delayed |
Last Transcript : DexCom, Inc.
| 1 day | -0.69% | ||
| 1 week | -7.47% | ||
| Current month | -8.42% | ||
| 1 month | -1.91% | ||
| 3 months | +7.81% | ||
| 6 months | +22.38% | ||
| Current year | +25.92% |
| 1 week | 71.8 |  | 77.8 |
| 1 month | 71.8 | | 79.2 |
| Current year | 48.5 | | 79.2 |
| 1 year | 46.88 | | 79.2 |
| 3 years | 46.88 | | 131.88 |
| 5 years | 46.88 | | 144.55 |
| 10 years | 9.12 | | 144.55 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jacob Leach
CEO | Chief Executive Officer | 47 | 01/01/2026 |
Jereme Sylvain
DFI | Director of Finance/CFO | 46 | 19/03/2021 |
Stacey Stewart
CTO | Chief Tech/Sci/R&D Officer | - | 01/05/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Kevin Sayer
CHM | Chairman | 68 | 30/07/2018 |
Nick Augustinos
BRD | Director/Board Member | 67 | 20/11/2009 |
Jacob Leach
BRD | Director/Board Member | 47 | 01/01/2026 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.10% | -7.47% | - | - | 3.19TCr | |
| -0.27% | -3.40% | -20.40% | +4.47% | 18TCr | |
| -0.54% | -0.16% | -1.18% | +14.92% | 12TCr | |
| -0.42% | -2.31% | +8.55% | +81.95% | 6.2TCr | |
| -0.49% | -6.75% | +11.83% | +44.52% | 5.06TCr | |
| +0.98% | -3.91% | -6.15% | -32.60% | 4.88TCr | |
| -0.77% | -6.94% | +7.54% | -19.62% | 3.19TCr | |
| -1.84% | -3.02% | - | - | 3.04TCr | |
| -0.24% | -0.50% | +33.10% | -14.30% | 2.38TCr | |
| -2.51% | -10.87% | -14.66% | +6.30% | 2.23TCr | |
| Average | -0.61% | -2.73% | +2.33% | +10.71% | 6.34TCr | |
| Weighted average by Cap. | -0.34% | -1.89% | -4.32% | +13.88% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 523Cr 450.04Cr 423.76Cr 386.11Cr 722.42Cr 50TCr 725.3Cr 5.02TCr 1.94TCr 25TCr 1.96TCr 1.92TCr 80TCr | 579.99Cr 499.08Cr 469.93Cr 428.18Cr 801.14Cr 55TCr 804.33Cr 5.57TCr 2.15TCr 28TCr 2.18TCr 2.13TCr 89TCr |
| Net income | 97Cr 84Cr 79Cr 72Cr 134.59Cr 9.27TCr 135.12Cr 935.65Cr 361.62Cr 4.72TCr 365.87Cr 357.92Cr 15TCr | 114.89Cr 99Cr 93Cr 85Cr 158.7Cr 11TCr 159.34Cr 1.1TCr 426.42Cr 5.57TCr 431.43Cr 422.05Cr 18TCr |
| Net Debt | -76Cr -65Cr -62Cr -56Cr -105.14Cr -7.24TCr -105.56Cr -730.91Cr -282.49Cr -3.69TCr -285.81Cr -279.6Cr -12TCr | -106.15Cr -91Cr -86Cr -78Cr -146.62Cr -10TCr -147.21Cr -1.02TCr -393.96Cr -5.15TCr -398.58Cr -389.92Cr -16TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/26/10 | €71.80 | -1.10% | 22 |
| 08/26/08 | €72.60 | -2.42% | 0 |
| 07/26/07 | €74.40 | -1.59% | 0 |
| 04/26/04 | €75.60 | -1.82% | 0 |
| 03/26/03 | €77.00 | -0.52% | 0 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- DXCM Stock
- DC4 Stock
Select your edition
All financial news and data tailored to specific country editions
